Source: FDASM

Ignite Health’s Fabio Gratton, Chief Innovation Officer, had the unique opportunity on January 28 to speak exclusively with Dr. Jean-Ah Kang at the FDA’s Silver Spring, MD office as a follow-up to the Part 15 Public Hearings on the use of the Internet and social media to promote FDA-regulated medical products. Dr. Kang is Special Assistant to the Director in the Division of Drug Marketing, Advertising and Communications (DDMAC), the government organization managing the hearing process.  The two-hour interview focused on the ongoing development of FDA regulations to govern promotion, as well as the results of the hearings and what the pharmaceutical industry can do to participate in the guidance process.

Read the Complete Interview.

Source: PharmaVOICE

Fabio Gratton, Chief Innovation Officer for Ignite, is featured in "The Last Word" for the January 2010 issue of PharmaVOICE.  In the article Gratton discusses his experience presenting at the November 2009 FDA public hearing on social media, as well as what the industry should do next, and how the changing landscape of Web 2.0 has become a hot button priority for many pharma companies.

Read Complete Article. 

Source: MedAdNews

Social media has been the dancing elephant in the living room of medical marketing ever since user-generated content on the Web became possible, and the furniture hasn’t stopped shaking since. But 2009 was a watershed year in terms of adoption and next steps, as pharmaceutical companies from AstraZeneca to Sanofi-Aventis...

Read the Complete Article.

Amy K wrote a great post about "The Plight of the Health Activist". In her post she expresses frustration about the sheer volume of information that today's consumer needs to process, and asks for people's suggestions or advice in terms of how best to manage it.

Read Fabio Gratton's response.

Source: Medical Marketing & Media

Think you’ve heard enough about the FDA Social Media Hearing held earlier this month. Granted, the gaggle of general and industry coverage was way more than one person can digest. So we asked four experts who spoke at the hearings to sit down with us and debate the issues. With so much at stake and so little clarity, we hope this hour long panel interview will help you figure out what it all means to you and your business.

Hear the complete podcast.